Syngen Biotech Co.,Ltd. (TPEX:8279)

Chimerix Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,124	2,014	1,837	1,931	1,471	1,311
Revenue Growth (YoY)	10.84%	9.60%	-4.84%	31.22%	12.19%	1.09%
Cost of Revenue	1,353	1,290	1,193	1,242	942.93	816.02
Gross Profit	770.35	723.94	643.92	688.15	528.34	495.41
Selling, General & Admin	361.12	354.38	302.88	262.63	197.02	194.51
Research & Development	59.87	59.34	46.76	45.32	49.52	43.42
Operating Expenses	415.14	420.64	341.06	325.78	246.86	236.15
Operating Income	355.21	303.3	302.86	362.38	281.48	259.27
Interest Expense	-7.47	-9.28	-8.86	-5.07	-3.21	-2.47
Interest & Investment Income	2.1	2.05	1.43	0.61	0.32	2.24
Earnings From Equity Investments	-0.42	-5.32	36.08	26.64	14.81	-
Currency Exchange Gain (Loss)	5.32	5.32	-1.93	10.29	-4.31	-1.61
Other Non Operating Income (Expenses)	-5.83	4.18	4.49	1.58	7.87	6.51
EBT Excluding Unusual Items	348.92	300.25	334.07	396.42	296.95	263.94
Gain (Loss) on Sale of Investments	-0.49	-0.49	0.02	0.21	0.98	-0.35
Gain (Loss) on Sale of Assets	-0.15	-0.15	-0.28	-0.21	-0.63	-0.21
Asset Writedown	-	-	-	-	-1.81	-
Pretax Income	348.28	299.61	333.8	396.42	295.49	263.38
Income Tax Expense	68.84	59.4	58.98	75.18	57.72	47.83
Net Income	279.44	240.21	274.83	321.24	237.77	215.55
Net Income to Common	279.44	240.21	274.83	321.24	237.77	215.55
Net Income Growth	18.10%	-12.60%	-14.45%	35.10%	10.31%	14.19%
Shares Outstanding (Basic)	27	27	27	27	27	27
Shares Outstanding (Diluted)	27	27	27	27	27	27
Shares Change (YoY)	0.08%	-	-0.01%	-0.00%	-0.01%	12.85%
EPS (Basic)	10.31	8.86	10.14	11.85	8.77	7.95
EPS (Diluted)	10.29	8.85	10.13	11.84	8.76	7.94
EPS Growth	17.85%	-12.64%	-14.44%	35.16%	10.33%	1.15%
Free Cash Flow	326.06	287.83	323.23	-306.79	274.83	-52.55
Free Cash Flow Per Share	12.01	10.61	11.91	-11.31	10.13	-1.94
Dividend Per Share	-	5.000	5.000	5.000	4.000	3.500
Dividend Growth	-	-	-	25.00%	14.29%	16.67%
Gross Margin	36.27%	35.95%	35.05%	35.64%	35.91%	37.78%
Operating Margin	16.73%	15.06%	16.48%	18.77%	19.13%	19.77%
Profit Margin	13.16%	11.93%	14.96%	16.64%	16.16%	16.44%
Free Cash Flow Margin	15.35%	14.29%	17.59%	-15.89%	18.68%	-4.01%
EBITDA	460.51	402.1	386.21	432.93	347.82	321.89
EBITDA Margin	21.68%	19.97%	21.02%	22.43%	23.64%	24.55%
D&A For EBITDA	105.3	98.8	83.35	70.56	66.34	62.62
EBIT	355.21	303.3	302.86	362.38	281.48	259.27
EBIT Margin	16.73%	15.06%	16.48%	18.77%	19.13%	19.77%
Effective Tax Rate	19.77%	19.83%	17.67%	18.96%	19.53%	18.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.